Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

Gurdeep Mannu

This prestigious fellowship provides support for excellent individuals to develop a clinical academic research career through a period of postdoctoral training. 

Based jointly between the Nuffield Department of Surgical Sciences (NDS) and the Nuffield Department of Population Health (NDPH), the award will allow Mr Mannu to start his independent research group – Surgical Epidemiology Group (SEG) – which is interested in translating epidemiological research to help in the care of surgical patients diagnosed with breast cancer.   

Breast cancer is the commonest cancer in women in the UK and ductal carcinoma in situ (DCIS) is its commonest pre-invasive form.

Mr Mannu’s research uses large datasets from routine data sources, observational studies, and data from randomised trials to better understand the epidemiology and optimal treatment of breast cancer.

The results of his research will help to identify ways to improve the surveillance of women after pre-invasive breast cancer, help translate existing research into the clinic, and streamline future randomised trials to improve treatments for future breast cancer patients. 

His research will also provide doctors and patients with improved information on the likely outcomes from various treatments to help in treatment decision-making.

Commenting on his success, Mr Mannu said: “I am delighted to receive this fellowship and am looking forward to undertaking research that will make a difference to women diagnosed with breast cancer.”